Recent developments in thyroid eye disease (scientific article)

Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment.

Q34394088

T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy

Q35314277

Impact of smoking on the response to treatment of thyroid associated ophthalmopathy

Q35591093

Current perspective on the pathogenesis of Graves' disease and ophthalmopathy.

Q35606170

6 Emergency treatment of Graves' ophthalmopathy

Q36773975

Orbital tissue-derived T lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigens

Q41180349

Long-term effects of Graves' ophthalmopathy on health-related quality of life

Q44011939

Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use?

Q44273235

Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.

Q50933902

A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy.

Q53359335

Modification of the Classification of the Eye Changes of Graves' Disease: Recommendations of the Ad Hoc Committee of The American Thyroid Association

Q67020629

The spectrum of thyroid disease in a community: the Whickham survey

Q67052046

Pathogenesis of Graves' ophthalmopathy

Q70513409

Cytokine antagonists: new ideas for the management of Graves' ophthalmopathy

Q71091804

Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic

Q72800952

Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study

Q73761107

Genetics of thyroid-associated ophthalmopathy: a play in search of a cast of characters

Q73893593

Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy

Q74010201

Prospective and controlled study of ophthalmopathy after radioiodine therapy for Graves' hyperthyroidism

Q74278650

Management of exophthalmos and related ocular changes in Graves' disease

Q74338185

A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy

Q74459180

Cigarette smoking and treatment outcomes in Graves ophthalmopathy

Q77458223

Graves' ophthalmopathy: natural history and treatment outcomes

Q77575202

P433

issue

7462

P407

language of work or name

English

Q1860

P921

main subject

eye disease

Q3041498

P304

page(s)

385-90

P577

publication date

2004-08-14

P1433

published in

The BMJ

Q546003

P1476

title

Recent developments in thyroid eye disease

P478

volume

329

Reverse relations

cites work (P2860)

Q35951373	Asymmetric ophthalmopathy in a hypothyroid patient
Q36897408	B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family
Q36596473	Cigarette smoking and thyroid eye disease: a systematic review
Q34103843	Description and evaluation of the first national patient and public involvement day for thyroid eye disease in the United Kingdom
Q33246233	Diagnosis and management of thyrotoxicosis
Q48338869	Does thyroid surgery for Graves' disease improve health-related quality of life?
Q64235270	Effect of orbital decompression on dysthyroid optic neuropathy: A retrospective case series
Q36765925	Endonasal bilateral simultaneous orbital decompression
Q36586184	Management of thyroid disorders
Q35617803	Ocular changes and approaches of ophthalmopathy in basedow - graves- parry- flajani disease.
Q24201984	Orbital radiotherapy for adult thyroid eye disease
Q24241938	Orbital radiotherapy for adult thyroid eye disease
Q34008360	Orbito-oculoplastic diseases in lagos: a 4-year prospective study
Q35025267	Outcome of thyroid associated ophthalmopathy treated by radiation therapy
Q38664411	Patients' expectations for the functional and psychosocial outcomes of orbital decompression surgery for thyroid eye disease: a qualitative study
Q55425970	Prevalence and severity of ocular involvement in Graves' disease according to sex and age: A clinical study from Babol, Iran.
Q30481543	Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: a multi-centre, double-masked, factorial randomised controlled trial
Q36497521	Recent developments in the medical treatment of thyroid eye disease
Q28081573	Rituximab in the Treatment of Thyroid Eye Disease: A Review
Q42801091	Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy
Q51729788	The impact of thyroid eye disease upon patients' wellbeing: a qualitative analysis.
Q81119337	Thyroid orbitopathy possibly predisposes to late-onset of periocular lymphoma
Q84020983	[Clinical and neuroradiological diagnostics in Graves' orbitopathy]